A potential new target for cancer immunotherapies
Tumors can use an enzyme called ART1 to thwart antitumor immune cells, making the enzyme a promising new target for immunity-boosting cancer treatments, according to a new study.
Materials provided by Weill Cornell Medicine. Note: Content may be edited for style and length.
Source link aaaaa